Highlights in soft tissue sarcomas and gastrointestinal stromal tumours (GIST) trials reported at ASCO 2017 Annual Meeting

Research output: Contribution to journalComment/debatepeer-review

Abstract

Herein, we summarise the results of the most relevant studies presented at the 2017 ASCO Annual Meeting in the field of soft tissue sarcomas (STSs) and gastrointestinal stromal tumours (GISTs). Innovations on the management of localised disease, highlights from the different experiences in the metastatic setting and large studies on rare histologies will be included. Special attention will be paid to results on immunotherapy, antiangiogenics use in histology with limited sensitivity to standard chemotherapy and new compounds. The preliminary results on the impact of the next generation sequencing in the everyday management of STS and GIST patients will be also discussed.

Original languageEnglish
Article number160
JournalBMC Medicine
Volume15
Issue number1
DOIs
Publication statusPublished - Aug 22 2017

Keywords

  • Antiangiogenic drugs
  • Chemotherapy
  • Gastrointestinal stromal tumours
  • Immunotherapy
  • Next generation sequencing
  • Preoperative treatment
  • Prognostic assessment
  • Sarcoma

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Highlights in soft tissue sarcomas and gastrointestinal stromal tumours (GIST) trials reported at ASCO 2017 Annual Meeting'. Together they form a unique fingerprint.

Cite this